We developed a hybrid capture-based target enrichment panel, the Canine Oncopanel, for the detection of a wide spectrum of mutation types in 284 cancer-related genes. To validate the ability of the Ca
Supplementary Table 2 RAS index of primary tumors, normal colonic mucosa, and metastatic lesions using the RASKET kit Tb denotes primary tumor tissue obtained before treatment by biopsy, Ts denotes pr
This NGS employed targeted capture of exonic and partially intronic regions of eight genes that are recommended by the NCCN guidelines and highly relevant to NSCLC personalized treatment regimens. The
